Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Arrhythmias

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 190 articles: HTML format

Single Articles

March 2024
1. QUINN R, Leader N, Lebovic G, Chow CM, et al
   Accuracy of Wearable Heart Rate Monitors During Exercise in Sinus Rhythm and Atrial Fibrillation.
   J Am Coll Cardiol. 2024;83:1177-1179.
   PubMed    
   
   
   
2. NINNI S, Dombrowicz D, de Winther M, Staels B, et al
   Genetic Factors Altering Immune Responses in Atrial Fibrillation: JACC Review Topic of the Week.
   J Am Coll Cardiol. 2024;83:1163-1176.
   PubMed     Abstract available
   
   
   
3. DIXIT S, Oranefo JU, Raad M
   Atrial Fibrillation Management With Antiarrhythmic Drug Therapy: Balancing Benefits and Bradycardia Risks.
   J Am Coll Cardiol. 2024;83:1039-1041.
   PubMed    
   
   
   
4. KIM YG, Lee HS, Kim H, Kim M, et al
   Association of Antiarrhythmic Drug Therapy With Syncope and Pacemaker Implantation in Patients With Atrial Fibrillation.
   J Am Coll Cardiol. 2024;83:1027-1038.
   PubMed     Abstract available
   
   
   
5. NASER JA, Alexandrino FB, Harada T, Michelena HI, et al
   The Natural History of Atrial Functional Mitral Regurgitation.
   J Am Coll Cardiol. 2024 Mar 17:S0735-1097(24)00413.
   PubMed     Abstract available
   
   
   
6. NEWMAN JD, O'Meara E, Bohm M, Savarese G, et al
   Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review.
   J Am Coll Cardiol. 2024;83:932-950.
   PubMed     Abstract available
   
   
   February 2024
7. BARIANI R, Rigato I, Celeghin R, Marinas MB, et al
   Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies.
   J Am Coll Cardiol. 2024;83:797-807.
   PubMed     Abstract available
   
   
   
8. YOO JE, Kim M, Kim B, Lee H, et al
   Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury.
   J Am Coll Cardiol. 2024;83:741-751.
   PubMed     Abstract available
   
   
   
9. ANDREOTTI F, Massetti M, Montalescot G
   Thrombosis, Bleeding, and the Promise of Factor XI(a) Inhibition.
   J Am Coll Cardiol. 2024;83:679-681.
   PubMed    
   
   
   
10. EIKELBOOM JW, Mundl H, Alexander JH, Caso V, et al
    Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.
    J Am Coll Cardiol. 2024;83:669-678.
    PubMed     Abstract available
    
    
    January 2024
11. BEJJANI A, Khairani CD, Assi A, Piazza G, et al
    When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:444-465.
    PubMed     Abstract available
    
    
    
12. DI BIASE L, Lakkireddy DJ, Marazzato J, Velasco A, et al
    Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:82-108.
    PubMed     Abstract available
    
    
    December 2023
13. MULLEN CA
    Apixaban for Children With Heart Disease.
    J Am Coll Cardiol. 2023;82:2310-2311.
    PubMed    
    
    
    November 2023
14. JOGLAR JA, Chung MK, Armbruster AL, Benjamin EJ, et al
    2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2023 Nov 30:S0735-1097(23)06465.
    PubMed     Abstract available
    
    
    
15. WIGGINS BS, Cibotti-Sun M, Moore MM
    2023 Atrial Fibrillation Guideline-at-a-Glance.
    J Am Coll Cardiol. 2023 Nov 23:S0735-1097(23)07853.
    PubMed    
    
    
    
16. QIAN F, Siscovick D
    Reply: Omega-3 Fatty Acids and Atrial Fibrillation: The Importance of the Clinical Question.
    J Am Coll Cardiol. 2023;82:e207.
    PubMed    
    
    
    
17. MYHRE PL
    Omega-3 Fatty Acids and Atrial Fibrillation: The Difference Between Dietary Consumption and Supplementation.
    J Am Coll Cardiol. 2023;82:e205.
    PubMed    
    
    
    
18. CHEN H, Xu Y
    Omega-3 Fatty Acids and Atrial Fibrillation Risk: A Controversy Resolved?
    J Am Coll Cardiol. 2023;82:e203.
    PubMed    
    
    
    
19. O'KEEFE EL, Lavie CJ, Elagizi A, Milani RV, et al
    Omega 3, Atrial Fibrillation, and Cardiovascular Outcomes.
    J Am Coll Cardiol. 2023;82:e201-e202.
    PubMed    
    
    
    
20. SUN G, Ahlehoff O, Fosbol EL, Schou M, et al
    Long-Term Incidence of Atrial Fibrillation in Patients With Autoimmune Disease.
    J Am Coll Cardiol. 2023;82:1969-1971.
    PubMed    
    
    
    
21. LAU ES, Di Achille P, Kopparapu K, Andrews CT, et al
    Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes.
    J Am Coll Cardiol. 2023;82:1936-1948.
    PubMed     Abstract available
    
    
    
22. SARNHOLM J, Ljotsson B, Braunschweig F
    Reply: Targeting Symptom Preoccupation in Atrial Fibrillation: A Promising Treatment Approach and Avenue for Future Research.
    J Am Coll Cardiol. 2023;82:e183-e184.
    PubMed    
    
    
    
23. ANDERSSON P, Coyne J
    Caution Warranted Regarding the Efficacy of iCBT in Patients With Symptomatic Paroxysmal Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:e181.
    PubMed    
    
    
    
24. WANG J, Jia R, Lu Y, Yu W, et al
    Postmenopausal Women With Atrial Fibrillation and Mental Health Symptoms: A Group Deserving Attention.
    J Am Coll Cardiol. 2023;82:e179.
    PubMed    
    
    
    
25. DESAI BOSTROM AE, Lundberg J
    Beyond the Surface: Scrutinizing Methodological Biases in a Study on iCBT for Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:e177.
    PubMed    
    
    
    October 2023
26. MARGOLIS G, Chee J, Kazatsker M, Roguin A, et al
    Etiology of Early-Onset Complete Atrioventricular Block and Use of Implanted Cardiac Electronic Devices.
    J Am Coll Cardiol. 2023;82:1804-1806.
    PubMed    
    
    
    
27. HALPERIN JL, Rothman KJ
    Initial Antithrombotic Therapy After Percutaneous Left Atrial Appendage Occlusion: Shifting Approaches to a Moving Target.
    J Am Coll Cardiol. 2023;82:1774-1776.
    PubMed    
    
    
    
28. KASKI JP, Norrish G
    Family Screening in Gene-Elusive Hypertrophic Cardiomyopathy: Time for a Change or Should We Tread Cautiously?
    J Am Coll Cardiol. 2023;82:1762-1764.
    PubMed    
    
    
    
29. CARVALHO PEP, Gewehr DM, Miyawaki IA, Nogueira A, et al
    Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion.
    J Am Coll Cardiol. 2023;82:1765-1773.
    PubMed     Abstract available
    
    
    
30. KRANTZ MJ, Stockbridge N, Kao DP, Klein MG, et al
    Reply: Loperamide-Associated Ventricular Arrhythmias.
    J Am Coll Cardiol. 2023;82:e159.
    PubMed    
    
    
    
31. FONT J, Alexandre J, Dolladille C, Milliez P, et al
    Loperamide-Associated Ventricular Arrhythmias.
    J Am Coll Cardiol. 2023;82:e157-e158.
    PubMed    
    
    
    
32. ARGO MB, Barron DJ, Eghtesady P, Yerebakan C, et al
    Outcomes After Hybrid Palliation for Infants With Critical Left Heart Obstruction.
    J Am Coll Cardiol. 2023;82:1427-1441.
    PubMed     Abstract available
    
    
    September 2023
33. BESSIERE F, Waldmann V, Combes N, Metton O, et al
    Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part II: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;82:1121-1130.
    PubMed     Abstract available
    
    
    
34. BESSIERE F, Waldmann V, Combes N, Metton O, et al
    Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part I: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;82:1108-1120.
    PubMed     Abstract available
    
    
    
35. PUJOL-LOPEZ M, Du Fay de Lavallaz J, Rangan P, Beaser A, et al
    Vasovagal Responses to Human Monomorphic Ventricular Tachycardia: Hemodynamic Implications From Sinus Rate Analysis.
    J Am Coll Cardiol. 2023;82:1096-1105.
    PubMed     Abstract available
    
    
    
36. D'AVILA A, D'Angelo RN
    Vasovagal Responses to Human Monomorphic Ventricular Tachycardia: Atropine to the Rescue.
    J Am Coll Cardiol. 2023;82:1106-1107.
    PubMed    
    
    
    
37. SCHWENNESEN HT, Andrade JG, Wood KA, Piccini JP, et al
    Ablation to Reduce Atrial Fibrillation Burden and Improve Outcomes: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:1039-1050.
    PubMed     Abstract available
    
    
    August 2023
38. KIRKELS FP, van Osta N, Rootwelt-Norberg C, Chivulescu M, et al
    Monitoring of Myocardial Involvement in Early Arrhythmogenic Right Ventricular Cardiomyopathy Across the Age Spectrum.
    J Am Coll Cardiol. 2023;82:785-797.
    PubMed     Abstract available
    
    
    
39. WESSELS JN, van Wezenbeek J, de Rover J, Smal R, et al
    Right Atrial Adaptation to Precapillary Pulmonary Hypertension: Pressure-Volume, Cardiomyocyte, and Histological Analysis.
    J Am Coll Cardiol. 2023;82:704-717.
    PubMed     Abstract available
    
    
    
40. MARTINEZ KA, Bos JM, Baggish AL, Phelan DM, et al
    Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death.
    J Am Coll Cardiol. 2023;82:661-670.
    PubMed     Abstract available
    
    
    
41. WALDMANN V, Marquie C, Bessiere F, Perrot D, et al
    Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2023;82:590-599.
    PubMed     Abstract available
    
    
    
42. BASKAR S, Czosek RJ, Spar DS
    A Look Beyond the Sports Field: A Paradigm of Shared Decision Making in Everyday Life.
    J Am Coll Cardiol. 2023;82:612-614.
    PubMed    
    
    
    
43. NEVES R, Bains S, Bos JM, MacIntyre CJ, et al
    Fatal Cardiac Arrhythmias During Electronic Gaming in Patients With Genetically Mediated Heart Diseases.
    J Am Coll Cardiol. 2023;82:603-611.
    PubMed     Abstract available
    
    
    
44. SROUBEK J, Vajapey R, Sipko JJ, Soltesz EG, et al
    First-in-Human Experience With Impella 5.0/5.5 for High-Risk Patients With Advanced Heart Failure Undergoing VT Ablation.
    J Am Coll Cardiol. 2023;82:469-471.
    PubMed    
    
    
    
45. STEINBERG JS, Kutyifa V
    Long-Term Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator System.
    J Am Coll Cardiol. 2023;82:398-400.
    PubMed    
    
    
    
46. GOLD MR, El-Chami MF, Burke MC, Upadhyay GA, et al
    Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
    J Am Coll Cardiol. 2023;82:383-397.
    PubMed     Abstract available
    
    
    July 2023
47. DENG W, Mansour M, Song B, Hou H, et al
    Fall Outcomes With Left Atrial Appendage Occlusion vs Direct Oral Anticoagulants for Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:379-381.
    PubMed    
    
    
    
48. MARON BJ, Estes NAM, Rowin EJ, Maron MS, et al
    Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective.
    J Am Coll Cardiol. 2023;82:353-373.
    PubMed     Abstract available
    
    
    
49. BALLANTYNE CM, Jia X
    Omega-3 Fatty Acids and Risk for Atrial Fibrillation: Big Fish or Small Fry?
    J Am Coll Cardiol. 2023;82:350-352.
    PubMed    
    
    
    
50. QIAN F, Tintle N, Jensen PN, Lemaitre RN, et al
    Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:336-349.
    PubMed     Abstract available
    
    
    
51. FITZGIBBONS TP
    Epicardial Adipose-Derived miR92a-3p: Stress Reduction Therapy?
    J Am Coll Cardiol. 2023;82:333-335.
    PubMed    
    
    
    
52. BURCZAK DR, Julakanti RR, Kara Balla A, Scott CG, et al
    Risk of Left Atrial Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:278-279.
    PubMed    
    
    
    
53. MCCABE PJ
    Beyond Drugs and Ablation: New Hope for Symptom Management in Patients With Paroxysmal Atrial Fibrillation?
    J Am Coll Cardiol. 2023;82:57-59.
    PubMed    
    
    
    
54. SARNHOLM J, Skuladottir H, Ruck C, Axelsson E, et al
    Cognitive Behavioral Therapy Improves Quality of Life in Patients With Symptomatic Paroxysmal Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:46-56.
    PubMed     Abstract available
    
    
    June 2023
55. TURNBULL S, Garikapati K, Bennett RG, Campbell TG, et al
    Utility of a Handheld, Single-Lead ECG Device for Diagnosis of Cardiac Arrhythmias.
    J Am Coll Cardiol. 2023;81:2292-2294.
    PubMed    
    
    
    
56. KRANTZ MJ, Rudo TJ, Haigney MCP, Stockbridge N, et al
    Ventricular Arrhythmias Associated With Over-the-Counter and Recreational Opioids.
    J Am Coll Cardiol. 2023;81:2258-2268.
    PubMed     Abstract available
    
    
    
57. JENTZER JC, Noseworthy PA, Kashou AH, May AM, et al
    Multidisciplinary Critical Care Management of Electrical Storm: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;81:2189-2206.
    PubMed     Abstract available
    
    
    May 2023
58. KAZI DS, DeJong C, Chen R, Wadhera RK, et al
    The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;81:2103-2111.
    PubMed     Abstract available
    
    
    
59. FERRICK KJ
    Atrial Fibrillation Ablation: Safety in Numbers.
    J Am Coll Cardiol. 2023;81:2100-2102.
    PubMed    
    
    
    
60. BENALI K, Khairy P, Hammache N, Petzl A, et al
    Procedure-Related Complications of Catheter Ablation for Atrial Fibrillation.
    J Am Coll Cardiol. 2023;81:2089-2099.
    PubMed     Abstract available
    
    
    
61. BOKMA JP, Geva T, Sleeper LA, Lee JH, et al
    Improved Outcomes After Pulmonary Valve Replacement in Repaired Tetralogy of Fallot.
    J Am Coll Cardiol. 2023;81:2075-2085.
    PubMed     Abstract available
    
    
    
62. MULLER SA, Gasperetti A, Bosman LP, Schmidt AF, et al
    Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy.
    J Am Coll Cardiol. 2023 May 9:S0735-1097(23)05543.
    PubMed     Abstract available
    
    
    April 2023
63. PATLOLLA SH, Schaff HV
    Reply: Atrial Fibrillation, Tricuspid Regurgitation, and Pacemaker: A Vicious Circle.
    J Am Coll Cardiol. 2023;81:e141.
    PubMed    
    
    
    
64. BONAPACE S, Marinelli A, Costa A, Trachanas K, et al
    Atrial Fibrillation, Tricuspid Regurgitation, and Pacemaker: A Vicious Circle.
    J Am Coll Cardiol. 2023;81:e139.
    PubMed    
    
    
    
65. MALLAT Z
    Fishing CHIPs to Predict Postoperative Atrial Fibrillation.
    J Am Coll Cardiol. 2023;81:1279-1282.
    PubMed    
    
    
    
66. NINNI S, Dombrowicz D, Kuznetsova T, Vicario R, et al
    Hematopoietic Somatic Mosaicism Is Associated With an Increased Risk of Postoperative Atrial Fibrillation.
    J Am Coll Cardiol. 2023;81:1263-1278.
    PubMed     Abstract available
    
    
    March 2023
67. HUIZAR JF, Kaszala K, Tan A, Koneru J, et al
    Abnormal Conduction-Induced Cardiomyopathy: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:1192-1200.
    PubMed     Abstract available
    
    
    
68. ALKHOULI M, Di Biase L, Natale A, Rihal CS, et al
    Nonthrombogenic Roles of the Left Atrial Appendage: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:1063-1075.
    PubMed     Abstract available
    
    
    
69. DEWITT E, Etheridge SP
    Sudden Cardiac Death in Adolescents: Allowing the Dead to Speak.
    J Am Coll Cardiol. 2023;81:1018-1020.
    PubMed    
    
    
    
70. FINOCCHIARO G, Radaelli D, D'Errico S, Papadakis M, et al
    Sudden Cardiac Death Among Adolescents in the United Kingdom.
    J Am Coll Cardiol. 2023;81:1007-1017.
    PubMed     Abstract available
    
    
    
71. GONZALEZ-CALLE D, Laffond A, Lopez-Tejero S, Sanchez PL, et al
    Impact of Peridevice Leak Outcomes After Left Atrial Appendage Closure: Does Size No Longer Matter?
    J Am Coll Cardiol. 2023;81:e79.
    PubMed    
    
    
    
72. NARAYAN SM, Rogers AJ
    Can Machine Learning Disrupt the Prediction of Sudden Death?
    J Am Coll Cardiol. 2023;81:962-963.
    PubMed    
    
    
    
73. GINDER C, Li J, Halperin JL, Akar JG, et al
    Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring.
    J Am Coll Cardiol. 2023;81:949-961.
    PubMed     Abstract available
    
    
    
74. REYNOLDS MR, Ahmad J
    The NCDR AFib Ablation Registry: Better Late Than Never?
    J Am Coll Cardiol. 2023;81:879-881.
    PubMed    
    
    
    
75. HSU JC, Darden D, Du C, Marine JE, et al
    Initial Findings From the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures.
    J Am Coll Cardiol. 2023;81:867-878.
    PubMed     Abstract available
    
    
    February 2023
76. VAN GELDER IC, Ekrami NK, Borof K, Fetsch T, et al
    Sex Differences in Early Rhythm Control of Atrial Fibrillation in the EAST-AFNET 4 Trial.
    J Am Coll Cardiol. 2023;81:845-847.
    PubMed    
    
    
    
77. GERGES C, Pistritto AM, Gerges M, Friewald R, et al
    Left Ventricular Filling Pressure in Chronic Thromboembolic Pulmonary Hypertension.
    J Am Coll Cardiol. 2023;81:653-664.
    PubMed     Abstract available
    
    
    
78. BISLERI G, Pandey AK, Verma S, Ali Hassan SM, et al
    Combined Minimally Invasive Surgical and Percutaneous Catheter Ablation of Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:606-619.
    PubMed     Abstract available
    
    
    
79. WILDE AAM, Schwartz PJ
    Long QT Syndrome, a Diagnosis That Warrants Expert Opinion and Expert Centers.
    J Am Coll Cardiol. 2023;81:487-489.
    PubMed    
    
    
    
80. BAINS S, Neves R, Bos JM, Giudicessi JR, et al
    Phenotypes of Overdiagnosed Long QT Syndrome.
    J Am Coll Cardiol. 2023;81:477-486.
    PubMed     Abstract available
    
    
    January 2023
81. VAN DEN EYNDE J, Possner M, Alahdab F, Veldtman G, et al
    Thromboprophylaxis in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2023;81:374-389.
    PubMed     Abstract available
    
    
    December 2022
82. RUF TF, Gossler TAM, von Bardeleben RS
    Understanding Atrial Fibrillation and Atrial Secondary Tricuspid Regurgitation: The Chicken or the Egg?
    J Am Coll Cardiol. 2022;80:2299-2300.
    PubMed    
    
    
    
83. PATLOLLA SH, Schaff HV, Nishimura RA, Stulak JM, et al
    Incidence and Burden of Tricuspid Regurgitation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2022;80:2289-2298.
    PubMed     Abstract available
    
    
    
84. FARHAN S, Silbiger JJ, Halperin JL, Zhang L, et al
    Pathophysiology, Echocardiographic Diagnosis, and Treatment of Atrial Functional Mitral Regurgitation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2314-2330.
    PubMed     Abstract available
    
    
    
85. MOORE JP, Marelli A, Burchill LJ, Chubb H, et al
    Management of Heart Failure With Arrhythmia in Adults With Congenital Heart Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2224-2238.
    PubMed     Abstract available
    
    
    
86. VOIGT N, Maack C, Pronto JRD
    Targeting Mitochondrial Calcium Handling to Treat Atrial Fibrillation.
    J Am Coll Cardiol. 2022;80:2220-2223.
    PubMed    
    
    
    
87. FOSSIER L, Panel M, Butruille L, Colombani S, et al
    Enhanced Mitochondrial Calcium Uptake Suppresses Atrial Fibrillation Associated With Metabolic Syndrome.
    J Am Coll Cardiol. 2022;80:2205-2219.
    PubMed     Abstract available
    
    
    November 2022
88. ISBISTER JC, Nowak N, Yeates L, Singer ES, et al
    Concealed Cardiomyopathy in Autopsy-Inconclusive Cases of Sudden Cardiac Death and Implications for Families.
    J Am Coll Cardiol. 2022;80:2057-2068.
    PubMed     Abstract available
    
    
    
89. PALDINO A, Dal Ferro M, Stolfo D, Gandin I, et al
    Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies.
    J Am Coll Cardiol. 2022;80:1981-1994.
    PubMed     Abstract available
    
    
    
90. SIEIRA J, Stroker E, Bala G, Overeinder I, et al
    Brugada Syndrome During Infancy and Childhood: 30 Years' Experience.
    J Am Coll Cardiol. 2022;80:1961-1962.
    PubMed    
    
    
    October 2022
91. WALDMANN V, Marquie C, Bouzeman A, Duthoit G, et al
    Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillator Therapy in Patients With Tetralogy of Fallot.
    J Am Coll Cardiol. 2022;80:1701-1703.
    PubMed    
    
    
    
92. DE FRUTOS F, Ochoa JP, Navarro-Penalver M, Baas A, et al
    Natural History of MYH7-Related Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2022;80:1447-1461.
    PubMed     Abstract available
    
    
    
93. LA GERCHE A, Wasfy MM, Brosnan MJ, Claessen G, et al
    The Athlete's Heart-Challenges and Controversies: JACC Focus Seminar 4/4.
    J Am Coll Cardiol. 2022;80:1346-1362.
    PubMed     Abstract available
    
    
    September 2022
94. KINLAY S
    Post-PCI Antithrombotic Treatment With High Bleeding Risk.
    J Am Coll Cardiol. 2022;80:1238-1240.
    PubMed    
    
    
    
95. VIJAYARAMAN P, Batul SA
    Left Bundle Branch Pacing for Cardiac Resynchronization: Are We Ready for a Leap of Faith?
    J Am Coll Cardiol. 2022;80:1217-1219.
    PubMed    
    
    
    
96. WANG Y, Zhu H, Hou X, Wang Z, et al
    Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy.
    J Am Coll Cardiol. 2022;80:1205-1216.
    PubMed     Abstract available
    
    
    
97. KANTER RJ
    Care of the Infant With Supraventricular Tachycardia: Toward a Better Paradigm.
    J Am Coll Cardiol. 2022;80:1173-1176.
    PubMed    
    
    
    
98. MOORE JA, Stephens SB, Kertesz NJ, Evans DL, et al
    Clinical Predictors of Recurrent Supraventricular Tachycardia in Infancy.
    J Am Coll Cardiol. 2022;80:1159-1172.
    PubMed     Abstract available
    
    
    
99. TZOU WS
    Insights From the Dilated Cardiomyopathy Ventricular Tachycardia Ablation Study: Wisdom Through Humility.
    J Am Coll Cardiol. 2022;80:1057-1059.
    PubMed    
    
    
    
100. ZEPPENFELD K, Wijnmaalen AP, Ebert M, Baldinger SH, et al
     Clinical Outcomes in Patients With Dilated Cardiomyopathy and Ventricular Tachycardia.
     J Am Coll Cardiol. 2022;80:1045-1056.
     PubMed     Abstract available
     
     
     
101. BENALI K, Martins RP, Guenancia C, Da Costa A, et al
     Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardias: Is the Debate Over?
     J Am Coll Cardiol. 2022;80:e77.
     PubMed    
     
     
     
102. ARENAL A, Avila P
     Reply: Survive the Threat of Slow VT.
     J Am Coll Cardiol. 2022;80:e79-e80.
     PubMed    
     
     
     
103. REIFFEL JA
     Slow Ventricular Tachycardia on Amiodarone: An Adverse Complication or an Efficacy Outcome.
     J Am Coll Cardiol. 2022;80:e75.
     PubMed    
     
     
     August 2022
104. CORBALAN R, Acevedo M
     Glifozins and Atrial Fibrillation.
     J Am Coll Cardiol. 2022 Aug 23. pii: S0735-1097(22)06612.
     PubMed    
     
     
     
105. MOHAMMADI-SHEMIRANI P, Chong M, Pare G
     Reply: Lipoprotein(a) and Atrial Fibrillation.
     J Am Coll Cardiol. 2022;80:e51.
     PubMed    
     
     
     
106. HEGELE RA
     Lipoprotein(a) and Atrial Fibrillation.
     J Am Coll Cardiol. 2022;80:e49-e50.
     PubMed    
     
     
     
107. BUTT JH, Kondo T, Jhund PS, Comin-Colet J, et al
     Dapagliflozin, atrial fibrillation, and heart failure with mildly reduced or preserved ejection fraction in DELIVER.
     J Am Coll Cardiol. 2022 Aug 13. pii: S0735-1097(22)06529.
     PubMed     Abstract available
     
     
     
108. SCHMIDT B, Chun KRJ
     Peridevice Leaks: The Plot Hole of Left Atrial Appendage Closure for Stroke Prophylaxis.
     J Am Coll Cardiol. 2022;80:484-485.
     PubMed    
     
     
     
109. DUKKIPATI SR, Holmes DR Jr, Doshi SK, Kar S, et al
     Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure.
     J Am Coll Cardiol. 2022;80:469-483.
     PubMed     Abstract available
     
     
     July 2022
110. SVENNBERG E
     How to Treat Patients With First-Diagnosed Atrial Fibrillation: The Less Clear Pattern?
     J Am Coll Cardiol. 2022;80:296-298.
     PubMed    
     
     
     
111. GOETTE A, Borof K, Breithardt G, Camm AJ, et al
     Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy.
     J Am Coll Cardiol. 2022;80:283-295.
     PubMed     Abstract available
     
     
     
112. DE BACKER J, Narula J
     Cardiolaminopathies: Weighing in on the Concept of Genotype-First Screening.
     J Am Coll Cardiol. 2022;80:60-62.
     PubMed    
     
     
     
113. LAZARTE J, Jurgens SJ, Choi SH, Khurshid S, et al
     LMNA Variants and Risk of Adult-Onset Cardiac Disease.
     J Am Coll Cardiol. 2022;80:50-59.
     PubMed     Abstract available
     
     
     
114. SOLOW EB, Bermas BL
     Hydroxychloroquine: Heart-Throb No More?
     J Am Coll Cardiol. 2022;80:47-49.
     PubMed    
     
     
     June 2022
115. GAUDINO M, Di Franco A, Rong LQ, Cao D, et al
     Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:2529-2539.
     PubMed     Abstract available
     
     
     
116. CURTIS AB, Korada SKC
     Should Atrial Fibrillation Be Included in Preoperative Risk Assessment for Noncardiac Surgery?
     J Am Coll Cardiol. 2022;79:2486-2488.
     PubMed    
     
     
     
117. PRASADA S, Desai MY, Saad M, Smilowitz NR, et al
     Preoperative Atrial Fibrillation and Cardiovascular Outcomes After Noncardiac Surgery.
     J Am Coll Cardiol. 2022;79:2471-2485.
     PubMed     Abstract available
     
     
     
118. AHMED A, Pothineni NVK, Charate R, Garg J, et al
     Inappropriate Sinus Tachycardia: Etiology, Pathophysiology, and Management: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:2450-2462.
     PubMed     Abstract available
     
     
     
119. TAKAHASHI T, Samuels BA, Li W, Parikh MA, et al
     Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.
     J Am Coll Cardiol. 2022;79:2367-2378.
     PubMed     Abstract available
     
     
     
120. AJOOLABADY A, Nattel S, Lip GYH, Ren J, et al
     Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:2349-2366.
     PubMed     Abstract available
     
     
     May 2022
121. RAJPAL S, Kahwash R, Tong MS, Paschke K, et al
     Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways.
     J Am Coll Cardiol. 2022;79:2144-2152.
     PubMed     Abstract available
     
     
     
122. CAMM AJ, Naccarelli GV, Mittal S, Crijns HJGM, et al
     The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:1932-1948.
     PubMed     Abstract available
     
     
     
123. FREEMAN JV, Higgins AY, Wang Y, Du C, et al
     Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
     J Am Coll Cardiol. 2022;79:1785-1798.
     PubMed     Abstract available
     
     
     
124. HOLMES DR JR
     Antithrombotic Therapy After Left Atrial Appendage Occlusion: Cornucopia and Gertrude Stein.
     J Am Coll Cardiol. 2022;79:1799-1801.
     PubMed    
     
     
     April 2022
125. KIM DS, Khandelwal A
     Lipoprotein(a) and Incident Atrial Fibrillation: Leveraging Nature's Randomization to Identify Novel Causal Associations.
     J Am Coll Cardiol. 2022;79:1591-1593.
     PubMed    
     
     
     
126. MOHAMMADI-SHEMIRANI P, Chong M, Narula S, Perrot N, et al
     Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study.
     J Am Coll Cardiol. 2022;79:1579-1590.
     PubMed     Abstract available
     
     
     
127. AMUTHAN R, Curtis AB
     Sex-Specific Considerations in Drug and Device Therapy of Cardiac Arrhythmias: JACC Focus Seminar 6/7.
     J Am Coll Cardiol. 2022;79:1519-1529.
     PubMed     Abstract available
     
     
     
128. SALEEM M, Costanzo MR
     Survive VT: A Step Closer to "Smashing" Ischemic Ventricular Tachycardia?
     J Am Coll Cardiol. 2022;79:1454-1457.
     PubMed    
     
     
     
129. ARENAL A, Avila P, Jimenez-Candil J, Tercedor L, et al
     Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
     J Am Coll Cardiol. 2022;79:1441-1453.
     PubMed     Abstract available
     
     
     
130. PICCINI JP, Harrington J
     Midregional Pro-Atrial Natriuretic Peptide and Atrial Fibrillation: Interesting Association or Practice Changing?
     J Am Coll Cardiol. 2022;79:1382-1384.
     PubMed    
     
     
     
131. SCHWEIZER J, Arnold M, Konig IR, Bicvic A, et al
     Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.
     J Am Coll Cardiol. 2022;79:1369-1381.
     PubMed     Abstract available
     
     
     March 2022
132. POWER DA, Lampert J, Camaj A, Bienstock SW, et al
     Cardiovascular Complications of Interatrial Conduction Block: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:1199-1211.
     PubMed     Abstract available
     
     
     
133. FRIEDMAN DJ, Qin L, Parzynski C, Heist EK, et al
     Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients.
     J Am Coll Cardiol. 2022;79:1050-1059.
     PubMed     Abstract available
     
     
     
134. MARWICK TH, Brugger N
     Effects of Atrial Fibrillation and Sinus Rhythm on Cardiac Remodeling and Valvular Regurgitation.
     J Am Coll Cardiol. 2022;79:962-964.
     PubMed    
     
     
     
135. SOULAT-DUFOUR L, Lang S, Addetia K, Ederhy S, et al
     Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation.
     J Am Coll Cardiol. 2022;79:951-961.
     PubMed     Abstract available
     
     
     February 2022
136. ROMANOV A, Lomivorotov V, Chernyavskiy A, Murtazin V, et al
     Temporary Spinal Cord Stimulation to Prevent Postcardiac Surgery Atrial Fibrillation: 30-Day Safety and Efficacy Outcomes.
     J Am Coll Cardiol. 2022;79:754-756.
     PubMed    
     
     
     
137. ZAFEIROPOULOS S, Doundoulakis I, Farmakis IT, Miyara S, et al
     Autonomic Neuromodulation for Atrial Fibrillation Following Cardiac Surgery: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:682-694.
     PubMed     Abstract available
     
     
     
138. LEYVA F, Zegard A, Okafor O, Foley P, et al
     Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device Implantation.
     J Am Coll Cardiol. 2022;79:665-678.
     PubMed     Abstract available
     
     
     
139. VRANCKX P, Angiolillo DJ, Valgimigli M
     Patients With Atrial Fibrillation and PCI or ACS: Does Predicted Risk Matter?
     J Am Coll Cardiol. 2022;79:428-431.
     PubMed    
     
     
     
140. HARSKAMP RE, Fanaroff AC, Lopes RD, Wojdyla DM, et al
     Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
     J Am Coll Cardiol. 2022;79:417-427.
     PubMed     Abstract available
     
     
     January 2022
141. VOLGMAN AS, Nair G, Lyubarova R, Merchant FM, et al
     Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:166-179.
     PubMed     Abstract available
     
     
     
142. MERCHANT FM
     Does Percutaneous Left Atrial Appendage Closure Stand the Test of Time?
     J Am Coll Cardiol. 2022;79:15-17.
     PubMed    
     
     
     December 2021
143. NORBY FL, Benjamin EJ, Alonso A, Chugh SS, et al
     Racial and Ethnic Considerations in Patients With Atrial Fibrillation: JACC Focus Seminar 5/9.
     J Am Coll Cardiol. 2021;78:2563-2572.
     PubMed     Abstract available
     
     
     
144. SALMASI S, De Vera MA, Safari A, Lynd LD, et al
     Longitudinal Oral Anticoagulant Adherence Trajectories in Patients With Atrial Fibrillation.
     J Am Coll Cardiol. 2021;78:2395-2404.
     PubMed     Abstract available
     
     
     
145. SAHA SA
     Premature Ventricular Complexes During Exercise in Asymptomatic Adults: Do They Deserve a Closer Look?
     J Am Coll Cardiol. 2021;78:2278-2280.
     PubMed    
     
     
     
146. REFAAT MM, Gharios C, Moorthy MV, Abdulhai F, et al
     Exercise-Induced Ventricular Ectopy and Cardiovascular Mortality in Asymptomatic Individuals.
     J Am Coll Cardiol. 2021;78:2267-2277.
     PubMed     Abstract available
     
     
     November 2021
147. MARQUEZ MF
     The Quest for the Evidence of Effectiveness of Implantable Cardioverter-Defibrillators in Long QT Syndrome.
     J Am Coll Cardiol. 2021;78:2089-2091.
     PubMed    
     
     
     
148. WANG M, Peterson DR, Rosero S, McNitt S, et al
     Effectiveness of Implantable Cardioverter-Defibrillators to Reduce Mortality in Patients With Long QT Syndrome.
     J Am Coll Cardiol. 2021;78:2076-2088.
     PubMed     Abstract available
     
     
     
149. TERTULIEN T, Magnani JW, Essien UR
     Racial and Ethnic Representation in Atrial Fibrillation Trials: CABANA and Beyond.
     J Am Coll Cardiol. 2021;78:e163-e164.
     PubMed    
     
     
     
150. SIMARD T, Jung RG, Hibbert B, Holmes DR Jr, et al
     Reply: Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account.
     J Am Coll Cardiol. 2021;78:e159.
     PubMed    
     
     
     
151. WANG X, Wang P, Pei H
     Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account.
     J Am Coll Cardiol. 2021;78:e157.
     PubMed    
     
     
     October 2021
152. OSMANCIK P, Herman D, Neuzil P, Hala P, et al
     Left Atrial Appendage Closure versus Non-Warfarin Oral Anticoagulation in Atrial Fibrillation: 4-Year Outcomes of PRAGUE-17.
     J Am Coll Cardiol. 2021 Oct 27. pii: S0735-1097(21)07895.
     PubMed     Abstract available
     
     
     
153. ERNAULT AC, Meijborg VMF, Coronel R
     Modulation of Cardiac Arrhythmogenesis by Epicardial Adipose Tissue: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:1730-1745.
     PubMed     Abstract available
     
     
     
154. ESCOBAR-LOPEZ L, Ochoa JP, Mirelis JG, Espinosa MA, et al
     Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.
     J Am Coll Cardiol. 2021;78:1682-1699.
     PubMed     Abstract available
     
     
     
155. BEHR ER
     J-Wave Syndromes, SCN5A, and Cardiac Conduction Reserve: Two Sides of the Same Coin?
     J Am Coll Cardiol. 2021;78:1618-1620.
     PubMed    
     
     
     
156. ZHANG ZH, Barajas-Martinez H, Xia H, Li B, et al
     Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.
     J Am Coll Cardiol. 2021;78:1603-1617.
     PubMed     Abstract available
     
     
     
157. ASATRYAN B, Odening KE, Reichlin T
     Myocardial Histopathology Studies in Brugada Syndrome Decedents: Structural Features of a Presumed Electrical Disease.
     J Am Coll Cardiol. 2021;78:1522-1524.
     PubMed    
     
     
     
158. MILES C, Asimaki A, Ster IC, Papadakis M, et al
     Biventricular Myocardial Fibrosis and Sudden Death in Patients With Brugada Syndrome.
     J Am Coll Cardiol. 2021;78:1511-1521.
     PubMed     Abstract available
     
     
     September 2021
159. LURIE A, Wang J, Healey JS, Wong JA, et al
     Reply: Effects of Cardiac Amyloidosis and Screening Approach on Left Atrial Thrombus Prevalence in Atrial Fibrillation.
     J Am Coll Cardiol. 2021;78:e91-e92.
     PubMed    
     
     
     
160. KADISH A, Jacobson J
     Sleep Patterns and Arrhythmias: Should This Keep Us Awake at Night?
     J Am Coll Cardiol. 2021;78:1208-1209.
     PubMed    
     
     
     
161. LI X, Zhou T, Ma H, Huang T, et al
     Healthy Sleep Patterns and Risk of Incident Arrhythmias.
     J Am Coll Cardiol. 2021;78:1197-1207.
     PubMed     Abstract available
     
     
     August 2021
162. ANDRADE JG, Wazni OM, Kuniss M, Hawkins NM, et al
     Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:914-930.
     PubMed     Abstract available
     
     
     
163. CASAS G, Limeres J, Oristrell G, Gutierrez-Garcia L, et al
     Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction.
     J Am Coll Cardiol. 2021;78:643-662.
     PubMed     Abstract available
     
     
     
164. BERG DD, Giugliano RP, Ruff CT, Tang M, et al
     A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48.
     J Am Coll Cardiol. 2021;78:634-636.
     PubMed    
     
     
     July 2021
165. WAZNI O, Saliba W, Hussein AA
     Device-Related Thrombus After Left Atrial Appendage Occlusion.
     J Am Coll Cardiol. 2021;78:314-316.
     PubMed    
     
     
     
166. SIMARD T, Jung RG, Lehenbauer K, Piayda K, et al
     Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion.
     J Am Coll Cardiol. 2021;78:297-313.
     PubMed     Abstract available
     
     
     
167. THOMAS KL, Al-Khalidi HR, Silverstein AP, Monahan KH, et al
     Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.
     J Am Coll Cardiol. 2021;78:126-138.
     PubMed     Abstract available
     
     
     
168. RUSSO AM
     Catheter Ablation Is Better Than Drugs for Treatment of AF in Racial and Ethnic Minorities.
     J Am Coll Cardiol. 2021;78:139-141.
     PubMed    
     
     
     June 2021
169. GRANGER CB, Pokorney SD
     Preventing and Managing Bleeding With Anticoagulation for Atrial Fibrillation.
     J Am Coll Cardiol. 2021;77:3002-3004.
     PubMed    
     
     
     
170. DI MARCO A, Brown PF, Bradley J, Nucifora G, et al
     Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy.
     J Am Coll Cardiol. 2021;77:2890-2905.
     PubMed     Abstract available
     
     
     
171. LURIE A, Wang J, Hinnegan KJ, McIntyre WF, et al
     Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.
     J Am Coll Cardiol. 2021;77:2875-2886.
     PubMed     Abstract available
     
     
     
172. KIRCHHOF P, Sinning C
     Thrombus or No Thrombus: Is That the Embolic Question?
     J Am Coll Cardiol. 2021;77:2887-2889.
     PubMed    
     
     
     
173. CHEN YC, Voskoboinik A, Gerche A, Marwick TH, et al
     Prevention of Pathological Atrial Remodeling and Atrial Fibrillation: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2846-2864.
     PubMed     Abstract available
     
     
     
174. TREVISAN F, Bertini M, Balla C, Pestelli G, et al
     Type 1 Brugada Pattern Is Associated With Echocardiography-Detected Delayed Right Ventricular Outflow Tract Contraction.
     J Am Coll Cardiol. 2021;77:2865-2867.
     PubMed    
     
     
     
175. RAO VU, Reeves DJ, Chugh AR, O'Quinn R, et al
     Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2693-2716.
     PubMed     Abstract available
     
     
     May 2021
176. TOBERT KE, Bos JM, Garmany R, Ackerman MJ, et al
     Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death.
     J Am Coll Cardiol. 2021 May 26. pii: S0735-1097(21)04779.
     PubMed     Abstract available
     
     
     
177. AKTAS MK, Younis A, Zareba W, Kutyifa V, et al
     Survival After Implantable Cardioverter-Defibrillator Shocks.
     J Am Coll Cardiol. 2021;77:2453-2462.
     PubMed     Abstract available
     
     
     
178. DEO R, Pothineni NVK
     The "Shocking" Reality of ICD Therapies.
     J Am Coll Cardiol. 2021;77:2463-2465.
     PubMed    
     
     
     
179. CHRISTENSEN AH, Nyholm BC, Vissing CR, Pietersen A, et al
     Natural History and Clinical Characteristics of the First 10 Danish Families With Familial ST-Depression Syndrome.
     J Am Coll Cardiol. 2021;77:2617-2619.
     PubMed    
     
     
     
180. PRIORI SG, Mazzanti A, Santiago DJ, Kukavica D, et al
     Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5.
     J Am Coll Cardiol. 2021;77:2592-2612.
     PubMed     Abstract available
     
     
     
181. GIUDICESSI JR, Ackerman MJ, Fatkin D, Kovacic JC, et al
     Precision Medicine Approaches to Cardiac Arrhythmias: JACC Focus Seminar 4/5.
     J Am Coll Cardiol. 2021;77:2573-2591.
     PubMed     Abstract available
     
     
     
182. NACCARELLI GV, Filippone EJ, Foy A
     Do Mineralcorticoid Receptor Antagonists Suppress Atrial Fibrillation/Flutter?
     J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04967.
     PubMed    
     
     
     
183. FILIPPATOS G, Bakris GL, Pitt B, Agarwal R, et al
     Finerenone Reduces Onset of Atrial Fibrillation in Patients with Chronic Kidney Disease and Type 2 Diabetes.
     J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04966.
     PubMed     Abstract available
     
     
     April 2021
184. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
     Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
     J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
     PubMed    
     
     
     March 2021
185. MUNTANE-CAROL G, Philippon F, Nault I, Faroux L, et al
     Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:1344-1356.
     PubMed     Abstract available
     
     
     
186. CALO L, Della Bona R, Martino A, Crescenzi C, et al
     Left Posterior Fascicular Block and Increased Risk of Sudden Cardiac Death in Young People.
     J Am Coll Cardiol. 2021;77:1143-1145.
     PubMed    
     
     
     February 2021
187. LYON AR, Citro R, Schneider B, Morel O, et al
     Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:902-921.
     PubMed     Abstract available
     
     
     
188. COHEN MI, Khairy P, Zeppenfeld K, Van Hare GF, et al
     Preventing Arrhythmic Death in Patients With Tetralogy of Fallot: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;77:761-771.
     PubMed     Abstract available
     
     
     January 2021
189. ARAI AE, Bradley AJ, Sirajuddin A
     Risk Stratification for Sudden Death and Arrhythmias: A Role for Gadolinium-Enhanced CMR.
     J Am Coll Cardiol. 2021;77:42-44.
     PubMed    
     
     
     
190. ZEGARD A, Okafor O, de Bono J, Kalla M, et al
     Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease.
     J Am Coll Cardiol. 2021;77:29-41.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.